Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Completed 3

Sponsor Class

OTHER 3INDUSTRY 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Barrett Esophagus 3Zollinger-Ellison Syndrome 2Stomach Ulcer 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Hot Flashes 1Esophagitis, Peptic 1Breast Neoplasms 1Advanced Non-small Cell Lung Cancer 1

Interventions

Esomeprazole 3Radiofrequency Ablation 2Endoscopy, Digestive System 2rofecoxib 1YF 476 1X-Rays 1Narrow Band Imaging 1Lansoprazole 1Endoscopy 1Diagnostic Imaging 1Dexlansoprazole 1Cryosurgery 1Blood Specimen Collection 1Biopsy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Barrett Esophagus × Esomeprazole × Clear all
NCT00637559 2011-01-25

Barrett's Esophagus - 315 - 3 Way Cross-Over

AstraZeneca

Phase 4 Completed
50 enrolled
Gastrointestinal

Barrett Esophagus

NCT00637988 2011-01-21

Barrett's Esophagus - 315 - 3 Way Cross Over

AstraZeneca

Phase 4 Completed
32 enrolled
Gastrointestinal

Barrett Esophagus

NCT00352261 2009-03-26

An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients

AstraZeneca

Phase 4 Completed
80 enrolled
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡